Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 13)
5 February 2026
Aurubis Meets Expectations, Raises 2025/26 Forecast
Q1 EBT at €105M, driven by higher metal results. Full-year forecast raised due to improved market outlook. ROCE stable despite high capital spending.
5 February 2026
AptarGroup Q4 and 2025 Financial Results
Q4 sales up 14%, net income down 26%. Annual sales up 5%, net income up 5%. $206M returned to shareholders in Q4, $486M annually. New $600M stock repurchase approved.
5 February 2026
Linde 2025 Financial Results Released
Linde reported $34 billion in 2025 sales, serving diverse markets with industrial gases and technologies for productivity, sustainability, and emissions reduction.
5 February 2026
Neste 2025 Financial Results Release
Strong 2025 results with improved EBITDA and cash flow. Renewable and oil product sales rose. Dividend proposed at EUR 0.20 per share. 2026 guidance: stable renewables, lower oil sales.
4 February 2026
LOTTE Chemical Plans 2026 Expansion in High-Performance Materials and Eco-Friendly Energy
Recorded KRW 18,483B revenue, KRW 943.6B loss in 2025. Focus on reducing commodity petrochemicals, expanding high-value materials, and boosting eco-friendly energy capacity.
4 February 2026
Lilly Q4 2025 Financial Results and 2026 Outlook
Q4 revenue rose 43% to $19.3B, EPS up 51%. FDA approved Kwikpen, expanded Jaypirca use. 2026 revenue guidance: $80B-$83B, EPS: $33.50-$35.00.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
4 February 2026
Messer's Helmut Kaschenz to Depart as CFO in 2026
Helmut Kaschenz to step down as CFO in 2026 after key achievements in finance and strategy. Successor not yet named.
4 February 2026
OMV Reports EUR 4.6 Billion Clean CCS Operating Result for 2025
OMV's 2025 results show strong cash flow, low leverage, and improved chemicals and fuels performance, despite lower energy results. Dividend proposed at EUR 4.40 per share.
4 February 2026
OMV Petrom 2025 Financial Results and Investments
Record investments of 7.8 bn lei amid market volatility; net income down 27% due to impairments; strategic focus on energy transition and regional gas growth.
4 February 2026
Borouge Reports $1.1 Billion Net Profit for 2025 with Record Sales and Operational Performance
Achieved 37% EBITDA margin, record production, and sales. Focused on high-value products, cost control, and innovation. Expanded capacity and maintained strong dividends.
4 February 2026
Equinor Q4 and 2025 Financial Results
Adjusted operating income reached USD 6.20B. Production grew 6% in Q4. Focus on cost reduction, capital discipline, and strategic growth in oil, gas, and power.
4 February 2026
UPM 2025 Financials: Strong Cash Flow, Strategic Moves
Q4 sales and EBIT down, but cash flow strong. Strategic actions include joint ventures, investments, and closures. Sustainability recognized with top ratings.
3 February 2026
Novo Nordisk Reports 6% Sales Growth in DKK, 10% at CER for 2025
Operating profit fell 1% in DKK, rose 6% at CER. US FDA approved oral GLP-1 for obesity. 2026 sales growth expected to decline due to pricing and competition. New treatments in pipeline.
3 February 2026
Novo Nordisk 2025 Financial Report
Sales rose 10% at CER, operating profit up 6%. US FDA approved oral GLP-1. 2026 outlook: sales/profit growth -5% to -13% at CER. New share repurchase program announced.
3 February 2026
DOMO Polymer Solutions Spain Enters Insolvency
The company is assessing solutions under court supervision. Operations in Blanes are paused, affecting 100 employees. Restructuring options are being reviewed.
3 February 2026
Merck Announces Q4 and Full-Year 2025 Financial Results, Highlights Pipeline Progress
Strong oncology and animal health sales, positive trial results, and strategic acquisitions drive growth. 2026 outlook projects sales up to $67B, with EPS impacted by acquisition charges.
3 February 2026
Aramco Completes $4 Billion Bond Issuance
Aramco issued $4B in bonds across four tranches, with attractive pricing and negative new issue premiums, reflecting strong credit quality and financial discipline.
3 February 2026
Ørsted Divests European Onshore Business to CIP
The transaction, valued at EUR 1.44 billion, is set to close in Q2 2026, refocusing efforts on offshore wind and strengthening financials.
3 February 2026
AkzoNobel Reports Q4 and FY 2025 Profit Margin Growth
Organic sales dipped, but efficiency boosted margins. Operating income rose, cash flow improved, and a merger with Axalta is proposed. No major market recovery expected in 2026.
3 February 2026
Boliden Q4 2025 Report: Strong Metal Prices Boost Performance
Stable production, record mine profits, and strong metal prices marked Q4. Operating profit reached SEK 4,061m, with a proposed dividend of SEK 11.00 per share.
2 February 2026
Equinor Sells Argentina Onshore Assets to Vista Energy
Equinor divests its Vaca Muerta onshore assets for $1.1B, enhancing financial flexibility and focusing on offshore opportunities.
30 January 2026
WACKER Increases Silicone Prices
Prices for silicone products rise due to increased platinum costs, affecting sectors like automotive and medical. Existing contracts will be amended.
30 January 2026
thyssenkrupp: From Decisions to Implementation in Transformation Journey
AGM approves agenda; TKMS listed on MDAX; share value up 135%; ACES 2030 model launched; €0.15 dividend; Supervisory Board re-elected; focus on sustainable success.
30 January 2026
Chevron Q4 2025 Financial Results
Earnings at $2.8B, adjusted $3.0B. Cash flow $10.8B, free cash $4.2B. Production up 12% globally, 16% U.S. Reserve replacement 158%. Dividend up 4% to $1.78/share.
30 January 2026
LyondellBasell 2025 Earnings Report
Net loss of $738M; $563M excluding items. EBITDA at $1.1B; $2.5B excluding items. Cash from operations $2.3B. Exceeded cash plan by $200M. European asset divestment on track for 2026.
29 January 2026
Dow Q4 2025 Financial Results
Net sales fell 9% YoY. GAAP net loss was $1.5B. Op. EBIT dropped $421M. Cost savings partly offset declines. Dividends totaled $251M. CEO highlights cost actions and future productivity goals.
29 January 2026
Iberdrola Sells Spanish Gas Plants to Edison Next
The sale includes five gas plants and four biomethane projects, aligning with a strategy to focus on electrification and renewable energy.
29 January 2026
Dow unveils Transform to Outperform for enhanced productivity and growth
Dow aims for $2B Op. EBITDA boost by simplifying operations, cutting costs, and modernizing customer service, with $1.1-1.5B in one-time costs, including severance for 4,500 roles.
29 January 2026
Eastman Reports Q4 and 2025 Financial Results
Generated nearly $1B cash, exceeded cost savings goals, increased production, and raised dividends for the 16th year, returning $500M to stockholders.
29 January 2026
Takeda Q3 FY2025 Results: VYVANSE® Generics Impact, Cost Management, and Upcoming Launches
Revenue and core profit declined, but operating profit rose. New drug applications submitted, with launches expected in 18 months, aiming for long-term growth.
← Previous
Next →